Nalbuphine Extended Release (Trevi Therapeutics)
纳布啡缓释制剂 (Trevi Therapeutics)
Report date: 2026/03/26 20:00:17
Base Information
Drug NameNalbuphine Extended Release (Trevi Therapeutics)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[7]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[14]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPenwest Pharmaceuticals Co
China Registration ClassN/A
Develop Information
Active CompaniesTrevi Therapeutics Inc
Inactive CompaniesN/A
Active Indications
Inactive Indications +[4]
Other Information
ATC CodeN/A
Related LinksN/A